Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae

  22 June 2024

Trichophyton indotineae is an emerging dermatophyte causing extensive tinea infections, often unresponsive to terbinafine. A retrospective cohort study in New York City found that 11 patients with T indotineae infections had widespread lesions, diagnostic delays, and terbinafine treatment failure. Fluconazole and griseofulvin improved outcomes in 2 of 4 and 2 of 5 instances, respectively. Itraconazole was generally effective, and the acquisition of infection was likely in Bangladesh. The study suggests that disease severity, diagnostic delays, and lack of response to typically used doses and durations of antifungals for tinea were common in this primarily immunocompetent patient cohort.

 

Further reading: JAMA Dermatology
Author(s): Avrom S. Caplan et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed